Total Visits

Views
Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: a Promising Approach for Target-Based Cancer Therapy127

Total Visits Per Month

September 2023October 2023November 2023December 2023January 2024February 2024March 2024April 2024May 2024June 2024July 2024
Design and Development of Small-Molecule Arylaldoxime/5-Nitroimidazole Hybrids as Potent Inhibitors of MARK4: a Promising Approach for Target-Based Cancer Therapy00156121435

File Visits

Views
Avecilla_Fernando_2020_Design_development_small-molecule_arylaldoxime5-nitroimidazole_hybrids.pdf205

Top country views

Views
United States79
Sweden16
Germany7
China5
Ireland5
Ukraine3
Argentina2
Canada1
Netherlands1
Russia1

Top cities views

Views
Louisville18
Ashburn15
Fairfield13
Dublin4
Mountain View4
Cambridge3
Hangzhou3
San Diego3
San Ramon3
Costa Mesa2